Skip to main content

Psoriasis

Psoriasis

Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices
NPF Endorsed Features
Although these drugs frequently are highly effective at treating psoriasis, prescribing them is only half the battle. Dermatologists and patients both face other challenges to access.
NPF Endorsed Features
About 30% of patients with psoriasis will develop this chronic, inflammatory comorbidity. Knowing how to recognize and treat it can help improve patient outcomes.
Podcast
Lawrence Green, MD, with George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for patients.
Derm Q&A
Concomitant HIV and psoriasis can be difficult to treat due to a variety of factors, including increased risk of opportunistic infections associated with some treatment options. Wilson Liao, MD, with the University of California San Francisco, discusses the challenges and treatment strategies for managing psoriasis and HIV.
NPF Endorsed Features
Recommendations include best practices for addressing noncutaneous aspects associated with psoriasis.
Features
The FDA approved halobetasol propionate tazarotene 0.01%/0.045% lotion for the treatment of plaque psoriasis. Lawrence Green, MD, spoke with The Dermatologist about how this therapy will benefit patients with mild disease.
NPF Endorsed Features
Recent updates address the latest evidence on the safety and efficacy of biologics.
Features
A 51-year-old African American woman with a more than 20-year history of severe plaque psoriasis presented to the clinic due to a flare-up of her symptoms, including moderate joint pain (but no muscle aches or weakness), enlargement of plaques, severe pruritus, flaking, and erythema. Her family history was noncontributory.
NPF Endorsed Features
Dermatologists may soon have 2 more FDA-approved drugs for effectively controlling plaque psoriasis.
Derm Dx
A 70-year-old man presented to the office with concern for a growth developing in a preexisting psoriatic plaque on the left elbow. The patient related that he had noticed this lesion for about 5 months.
Back to Top